HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums

This article was originally published in The Rose Sheet

Executive Summary

Fragrance marketer is terminating its licensing deal with LVMH-owned designer label Celine "by mutual agreement," company reports March 14. Agreement, which was slated to last until Dec. 31, 2011, will now end Dec. 31, 2007, Inter Parfums says, adding dissolution of the partnership is not expected to have a noticeable effect on its overall business. Firm introduced premier Celine scent in 2001, and more recently launched Celine Fever in the U.S. Other designer brands in Inter Parfums' fragrance portfolio include Burberry, Paul Smith and Lanvin...

Fragrance marketer is terminating its licensing deal with LVMH-owned designer label Celine "by mutual agreement," company reports March 14. Agreement, which was slated to last until Dec. 31, 2011, will now end Dec. 31, 2007, Inter Parfums says, adding dissolution of the partnership is not expected to have a noticeable effect on its overall business. Firm introduced premier Celine scent in 2001, and more recently launched Celine Fever in the U.S. Other designer brands in Inter Parfums' fragrance portfolio include Burberry , Paul Smith and Lanvin ....

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel